Semaglutide yog ib qho tshuaj siv rau kev kho mob ntshav qab zib hom 2 thiab tswj qhov hnyav. Nws feem ntau pab tswj cov ntshav qab zib thiab lub cev hnyav los ntawm kev ua cov tshuaj hormones hauv lub cev hu ua glucagon-zoo li peptide-1 (GLP-1).

Semaglutide tsis yog tsuas yog ua tau zoo ntawm kev txo cov ntshav qab zib, tab sis kuj muaj cov txiaj ntsig zoo rau kev mob plawv. Cov kev tshawb fawb qhia tias ntev - siv cov tshuaj yuav txo tau cov xwm txheej ntawm cov hlab plawv-xws li mob plawv thiab mob stroke- hauv cov neeg mob ntshav qab zib hom 2.

Raws li GLP-1 receptor agonist, semaglutide txhim kho insulin secretion thiab txo cov piam thaj ntau lawm, yog li tswj tau cov piam thaj hauv ntshav tom qab noj mov (tom qab noj mov). Qhov no yog qhov tseem ceeb tshwj xeeb rau cov neeg mob ntshav qab zib hom 2, vim tias qhov xwm txheej feem ntau cuam tshuam nrog insulin tsis kam thiab tsis txaus cov tshuaj insulin.

Cov kev tshawb fawb soj ntsuam tau pom tias cov neeg mob kho nrog semaglutide tau ntsib qhov txo qis ntawm 1-1.5 feem pua ​​​​cov ntsiab lus hauv glycated hemoglobin (HbA1c), qhia tau tias muaj kev txhim kho tseem ceeb hauv kev tswj ntshav qab zib. Tsis tas li ntawd, qee qhov kev tshawb fawb pom tau tias semaglutide muaj txiaj ntsig zoo rau kev tswj hwm qhov hnyav, nrog rau cov neeg siv ua tiav qhov hnyav ntawm kwv yees li 5-10%.